SEC CIK 1485939
ABERCROMBIE GEORGE B
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| INVAview stock → | 285,479 | 2018-08-21 |
| BCRXview stock → | 36,431 | 2024-06-12 |
Position History — BCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-06-12 | Grant / award (derivative) | 49,933 | $0.00 | 49,933 |
| 2024-06-12 | Grant / award | 6,820 | $0.00 | 36,431 |
| 2023-06-13 | Grant / award (derivative) | 39,072 | $0.00 | 39,072 |
| 2023-06-13 | Grant / award | 16,745 | $0.00 | 29,611 |
| 2022-06-07 | Grant / award (derivative) | 30,022 | $0.00 | 30,022 |
| 2022-06-07 | Grant / award | 12,866 | $0.00 | 12,866 |
| 2022-04-18 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2022-04-18 | Option exercise | 5,000 | $3.32 | 5,000 |
| 2022-04-18 | Open-market sale | 5,000 | $11.04 | 0 |
| 2022-02-15 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2022-02-15 | Open-market sale | 5,000 | $18.50 | 0 |
| 2022-02-15 | Option exercise | 5,000 | $3.32 | 5,000 |
| 2021-11-15 | Option exercise (derivative) | 5,000 | $0.00 | 10,000 |
| 2021-11-15 | Option exercise | 5,000 | $3.32 | 5,000 |
| 2021-11-15 | Open-market sale | 5,000 | $12.27 | 0 |
| 2021-09-15 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2021-09-15 | Option exercise | 5,000 | $2.63 | 5,000 |
| 2021-09-15 | Open-market sale | 5,000 | $15.06 | 0 |
| 2021-09-10 | Option exercise (derivative) | 30,000 | $0.00 | 0 |
| 2021-09-10 | Option exercise | 30,000 | $2.91 | 74,000 |
| 2021-09-10 | Option exercise | 11,000 | $1.71 | 14,000 |
| 2021-09-10 | Option exercise | 30,000 | $3.22 | 44,000 |
| 2021-09-10 | Open-market sale | 74,000 | $15.09 | 0 |
| 2021-07-15 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2021-07-15 | Option exercise | 5,000 | $2.63 | 8,000 |
| 2021-07-15 | Open-market sale | 5,000 | $15.69 | 3,000 |
| 2021-05-25 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2021-05-24 | Option exercise (derivative) | 6,667 | $0.00 | 10,000 |
| 2021-05-24 | Option exercise | 6,667 | $2.63 | 9,667 |
| 2021-05-24 | Open-market sale | 6,667 | $13.90 | 3,000 |
| 2021-05-10 | Open-market sale | 7,000 | $12.70 | 3,000 |
| 2020-05-12 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2019-05-29 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2018-06-20 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2017-05-24 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2016-05-23 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2015-05-20 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2014-05-02 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2014-03-31 | Option exercise (derivative) | 4,000 | $0.00 | 11,000 |
| 2014-03-31 | Option exercise | 4,000 | $1.71 | 10,000 |
| 2013-11-12 | Open-market buy | 3,000 | $6.19 | 6,000 |
| 2013-05-31 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2013-03-05 | Open-market buy | 3,000 | $1.23 | 3,000 |
| 2012-05-23 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2011-10-10 | Grant / award (derivative) | 16,667 | $0.00 | 16,667 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.